|
USP4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.496900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.872400E-02 |
| Normal-vs-Stage2 |
1.545850E-01 |
| Normal-vs-Stage3 |
1.299480E-03 |
| Normal-vs-Stage4 |
2.89610002646157E-09 |
| Stage1-vs-Stage2 |
6.178800E-01 |
| Stage1-vs-Stage3 |
1.501550E-02 |
| Stage1-vs-Stage4 |
1.144960E-03 |
| Stage2-vs-Stage3 |
1.813800E-01 |
| Stage2-vs-Stage4 |
8.104600E-03 |
| Stage3-vs-Stage4 |
1.278630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.991620E-02 |
| Normal-vs-AfricanAmerican |
1.299660E-02 |
| Normal-vs-Asian |
1.725840E-01 |
| Caucasian-vs-AfricanAmerican |
4.075400E-01 |
| Caucasian-vs-Asian |
3.548000E-01 |
| AfricanAmerican-vs-Asian |
5.144800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.047100E-04 |
| Normal-vs-Female |
8.139400E-01 |
| Male-vs-Female |
8.384200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.819200E-03 |
| Normal-vs-Extreme_Weight |
9.400200E-04 |
| Normal-vs-Obese |
1.603640E-01 |
| Normal-vs-Extreme_Obese |
4.816400E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.032800E-01 |
| Normal_Weight-vs-Obese |
1.924430E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.493600E-01 |
| Extreme_Weight-vs-Obese |
1.101620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.026000E-01 |
| Obese-vs-Extreme_Obese |
1.583000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.688210E-01 |
| Normal-vs-Age(41-60Yrs) |
1.425440E-01 |
| Normal-vs-Age(61-80Yrs) |
5.142900E-03 |
| Normal-vs-Age(81-100Yrs) |
4.337300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.889200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.696800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.385800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.745400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.362000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.938390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.706360E-01 |
| Normal-VS-Type2 PRCC |
3.83289999961178E-07 |
| Normal-VS-KIRP CIMP |
4.118700E-03 |
| Normal-VS-Unclassified PRCC |
6.056400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.84190000002338E-06 |
| Type1 PRCC-VS-KIRP CIMP |
6.123600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.621600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.656800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.642000E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
1.811580E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.77220000000023E-05 |
| Normal-vs-N1 |
2.4752999999933E-05 |
| Normal-vs-N2 |
1.51292999999164E-05 |
| N0-vs-N1 |
1.459770E-01 |
| N0-vs-N2 |
2.047600E-01 |
| N1-vs-N2 |
5.659800E-01 |
|
|
